Transcend Capital Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $642K | Buy |
5,788
+318
| +6% | +$35.3K | 0.05% | 296 |
|
|
2025
Q1 | $613K | Sell |
5,470
-149
| -3% | -$16.7K | 0.04% | 323 |
|
|
2024
Q4 | $519K | Sell |
5,619
-2,787
| -33% | -$257K | 0.04% | 342 |
|
|
2024
Q3 | $705K | Buy |
8,406
+89
| +1% | +$7.46K | 0.05% | 321 |
|
|
2024
Q2 | $571K | Buy |
8,317
+45
| +0.5% | +$3.09K | 0.04% | 326 |
|
|
2024
Q1 | $606K | Buy |
8,272
+1,614
| +24% | +$118K | 0.05% | 293 |
|
|
2023
Q4 | $539K | Buy |
6,658
+72
| +1% | +$5.83K | 0.05% | 297 |
|
|
2023
Q3 | $494K | Buy |
6,586
+490
| +8% | +$36.7K | 0.05% | 291 |
|
|
2023
Q2 | $470K | Buy |
6,096
+95
| +2% | +$7.32K | 0.04% | 310 |
|
|
2023
Q1 | $498K | Sell |
6,001
-18,980
| -76% | -$1.57M | 0.05% | 290 |
|
|
2022
Q4 | $2.14M | Sell |
24,981
-1,540
| -6% | -$132K | 0.23% | 108 |
|
|
2022
Q3 | $1.64M | Buy |
26,521
+510
| +2% | +$31.5K | 0.18% | 133 |
|
|
2022
Q2 | $1.61M | Buy |
26,011
+88
| +0.3% | +$5.44K | 0.17% | 143 |
|
|
2022
Q1 | $1.54M | Buy |
25,923
+8,296
| +47% | +$493K | 0.14% | 167 |
|
|
2021
Q4 | $1.28M | Hold |
17,627
| – | – | 0.11% | 191 |
|
|
2021
Q3 | $1.19M | Sell |
17,627
-128
| -0.7% | -$8.67K | 0.11% | 196 |
|
|
2021
Q2 | $1.22M | Sell |
17,755
-230
| -1% | -$15.9K | 0.18% | 134 |
|
|
2021
Q1 | $1.16M | Sell |
17,985
-2,261
| -11% | -$146K | 0.14% | 162 |
|
|
2020
Q4 | $1.18M | Sell |
20,246
-19
| -0.1% | -$1.11K | 0.16% | 148 |
|
|
2020
Q3 | $1.28M | Buy |
20,265
+4,627
| +30% | +$292K | 0.23% | 97 |
|
|
2020
Q2 | $1.2M | Sell |
15,638
-3,954
| -20% | -$304K | 0.39% | 74 |
|
|
2020
Q1 | $1.47M | Buy |
+19,592
| New | +$1.47M | 0.44% | 68 |
|